Takeshi Kishida

8.9k total citations
148 papers, 4.6k citations indexed

About

Takeshi Kishida is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Takeshi Kishida has authored 148 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 49 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Takeshi Kishida's work include Renal cell carcinoma treatment (48 papers), Prostate Cancer Treatment and Research (22 papers) and Renal and related cancers (19 papers). Takeshi Kishida is often cited by papers focused on Renal cell carcinoma treatment (48 papers), Prostate Cancer Treatment and Research (22 papers) and Renal and related cancers (19 papers). Takeshi Kishida collaborates with scholars based in Japan, United States and United Kingdom. Takeshi Kishida's co-authors include Masahiro Yao, Farida Latif, Berton Zbar, Noboru Nakaigawa, Yoji Nagashima, Eamonn R. Maher, Keiichi Kondo, Ali Porbaha, Masahiko Hosaka and Satoru Shibuya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Takeshi Kishida

135 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Kishida Japan 38 2.8k 1.8k 1.5k 790 551 148 4.6k
Gustavo Ayala United States 41 2.5k 0.9× 2.3k 1.3× 1.1k 0.7× 1.9k 2.4× 1.8k 3.2× 118 6.8k
Masahito Tamura Japan 27 3.0k 1.1× 457 0.3× 547 0.4× 678 0.9× 370 0.7× 121 4.9k
Rafael Sirera Spain 26 1.3k 0.4× 765 0.4× 920 0.6× 1.1k 1.4× 150 0.3× 83 2.7k
Benjamin F. Calvo United States 29 1.1k 0.4× 486 0.3× 983 0.6× 1.5k 1.9× 612 1.1× 68 3.1k
Christopher W. Gregory United States 30 1.6k 0.6× 2.2k 1.2× 590 0.4× 527 0.7× 157 0.3× 93 4.3k
Hua Zhong China 16 1.9k 0.7× 263 0.1× 1.7k 1.1× 545 0.7× 119 0.2× 46 3.0k
Michael R. Cooper United States 29 1.3k 0.5× 1.2k 0.7× 649 0.4× 1.3k 1.6× 360 0.7× 104 3.8k
Masashi Nakayama Japan 25 1.1k 0.4× 928 0.5× 509 0.3× 664 0.8× 558 1.0× 142 2.7k
Toru Shibata Japan 29 631 0.2× 403 0.2× 566 0.4× 285 0.4× 283 0.5× 126 2.6k
Michele Magni Italy 29 1.7k 0.6× 352 0.2× 387 0.3× 1.3k 1.6× 986 1.8× 96 5.2k

Countries citing papers authored by Takeshi Kishida

Since Specialization
Citations

This map shows the geographic impact of Takeshi Kishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Kishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Kishida more than expected).

Fields of papers citing papers by Takeshi Kishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Kishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Kishida. The network helps show where Takeshi Kishida may publish in the future.

Co-authorship network of co-authors of Takeshi Kishida

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Kishida. A scholar is included among the top collaborators of Takeshi Kishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Kishida. Takeshi Kishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okubo, Yoichiro, Rika Kasajima, Shinya Sato, et al.. (2025). Cribriform pattern and IDC ‐P in prostate biopsies: prognostic relevance and reporting in metastatic disease. The Journal of Pathology Clinical Research. 11(6). e70052–e70052.
2.
Usui, Keisuke, et al.. (2025). Short-term outcomes of triplet therapy in metastatic hormone-sensitive prostate cancer in older adults: a retrospective, single-center real-world cohort study. International Urology and Nephrology. 57(11). 3543–3551. 1 indexed citations
3.
Suzuki, Takahisa, et al.. (2024). Retroperitoneal low‐grade fibromyxoid sarcoma. IJU Case Reports. 7(3). 255–258.
4.
Suzuki, Takahisa, et al.. (2024). Retroperitoneal Doege–Potter syndrome with intraoperative blood glucose monitoring. IJU Case Reports. 7(5). 391–394.
5.
Wei, Feifei, Taku Kouro, Yuko Nakamura, et al.. (2024). Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation. Computational and Structural Biotechnology Journal. 23. 859–869. 6 indexed citations
6.
Sato, Shinya, Toru Hiruma, Mitsuyo Yoshihara, et al.. (2023). Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Science. 114(6). 2674–2688. 17 indexed citations
7.
Kishida, Takeshi, et al.. (2023). Predictors of the development of febrile neutropenia in chemotherapy for advanced germ cell tumors. International Journal of Urology. 31(2). 134–138. 1 indexed citations
8.
Yamashita, Shinichi, Ken‐ichi Kakimoto, Motohide Uemura, et al.. (2023). Sexual function using the EORTC QLQ‐TC26 in testicular cancer survivors: A multi‐institutional, cross‐sectional study. International Journal of Urology. 30(11). 1044–1050. 2 indexed citations
9.
Yamashita, Shinichi, Ken‐ichi Kakimoto, Motohide Uemura, et al.. (2022). Association of financial toxicity with quality of life in testicular cancer survivors. International Journal of Urology. 29(12). 1526–1534. 13 indexed citations
10.
Kawahara, Takashi, Koji Kawai, Takahiro Kojima, et al.. (2022). Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors. International Journal of Urology. 29(7). 741–747. 6 indexed citations
11.
Tatenuma, Tomoyuki, et al.. (2019). Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction. Journal of Palliative Medicine. 23(2). 254–258. 8 indexed citations
12.
Tatenuma, Tomoyuki, Takashi Kawahara, Narihiko Hayashi, et al.. (2019). The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer. BioMed Research International. 2019. 1–5. 5 indexed citations
13.
Yamazaki, Haruhiko, Takeshi Kishida, Hiroyuki Iwasaki, et al.. (2018). Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases. Case Reports in Endocrinology. 2018. 1–5. 4 indexed citations
14.
Yasui, Masato, et al.. (2018). Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence. SHILAP Revista de lepidopterología. 2018. 1–5. 5 indexed citations
15.
Kishida, Takeshi, et al.. (2009). NUMERICAL STUDY OF WIND VELOCITY MEASURED ON THE ROOFTOP OF A TALL BUILDING IN CITY. Journal of Structural and Construction Engineering (Transactions of AIJ). 74(643). 1559–1565. 1 indexed citations
16.
Yao, Masahiro, Ying Huang, Kéiko Hattori, et al.. (2007). Expression of Adipose Differentiation-Related Protein: A Predictor of Cancer-Specific Survival in Clear Cell Renal Carcinoma. Clinical Cancer Research. 13(1). 152–160. 57 indexed citations
17.
Hattori, Kéiko, Ying Huang, Futoshi Sano, et al.. (2006). Vascular Cell Adhesion Molecule 1 Predicts Cancer-Free Survival in Clear Cell Renal Carcinoma Patients. Clinical Cancer Research. 12(24). 7339–7346. 37 indexed citations
18.
Morris, Mark R., Dean Gentle, Mahera Abdulrahman, et al.. (2005). Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma. Cancer Research. 65(11). 4598–4606. 95 indexed citations
19.
Yao, Masahiro, Keiichi Kondo, Minoru Yoshida, Takeshi Kishida, & Taro Shuin. (1999). MOLECULAR GENETICS OF THE KIDNEY CANCERS ; IMPLICATION OF THE VHL TUMOR SUPPRESSOR GENE. 46. 205–214. 1 indexed citations
20.
Kishida, Takeshi, et al.. (1994). Genotype-phenotype correlations in von Hippel-Lindau disease (VHL). The American Journal of Human Genetics. 55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustavo Ayala Breakdown of academic impact, for papers by Masahito Tamura Breakdown of academic impact, for papers by Rafael Sirera Breakdown of academic impact, for papers by Benjamin F. Calvo Breakdown of academic impact, for papers by Christopher W. Gregory Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by Michael R. Cooper Breakdown of academic impact, for papers by Masashi Nakayama Breakdown of academic impact, for papers by Toru Shibata Breakdown of academic impact, for papers by Michele Magni
Rankless by CCL
2026